Open AccessRemission of Seronegative Rheumatoid Arthritis Associated with the Treatment for Essential Thrombocythemia with Mercaptopurine and Hydroxycarbamide
Author(s) -
В. А. Саварина
Publication year - 2020
Publication title -
problemy zdorovʹâ i èkologii
Language(s) - English
Resource type - Journals
eISSN - 2708-6011
pISSN - 2220-0967
DOI - 10.51523/2708-6011.2020-17-1-16
Subject(s) - essential thrombocythemia , hydroxycarbamide , medicine , rheumatoid arthritis , aspirin , mercaptopurine , arthritis , immunology , disease , polycythemia vera , dermatology
The article presents a clinical case of seronegative rheumatoid arthritis (RA) in a 64-year-old man suffering from essential thrombocythemia for 10 years. The diagnosis of RA was verified 6 years ago; the patient has not been taking any disease-modifying antirheumatic drugs and only has undergone the treatment for thrombocythemia (hydroxycarbamide + mercaptopurine + aspirin). During this time, no activity of rheumatic pathology has been noted, which makes it possible to surmise the achievement of stable clinical and laboratory remission associated with the intake of cytostatics provided that the diagnosis is verified correctly.